48 weeks pegylated interferon alpha-2a is superior to 24 weeks of pegylated interferon alpha-2b in achieving hepatitis B e antigen seroconversion in chronic hepatitis B infection. [electronic resource]
Producer: 20060629Description: 1171-8 p. digitalISSN:- 0269-2813
- Adult
- Alanine Transaminase -- blood
- Antibodies, Viral -- blood
- Antiviral Agents -- administration & dosage
- DNA, Viral -- blood
- Drug Administration Schedule
- Female
- Hepatitis B -- enzymology
- Hepatitis B e Antigens -- immunology
- Hepatitis B, Chronic -- drug therapy
- Humans
- Interferon alpha-2
- Interferon-alpha -- administration & dosage
- Male
- Middle Aged
- Polyethylene Glycols -- administration & dosage
- Proportional Hazards Models
- Recombinant Proteins
- Retrospective Studies
- Time Factors
- Treatment Outcome
- Viral Load
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.